Influenza B M1 activators represent a class of compounds that specifically interact with the matrix protein 1 (M1) of the Influenza B virus. The M1 protein is a multifunctional component that is critical to the virus's life cycle, as it is involved in virus assembly, budding, and structural integrity of the viral particles. Its role is principally structural, forming a matrix layer just beneath the viral envelope that provides shape and rigidity to the viral particle. The activators of M1 are believed to enhance the natural function of the M1 protein, which could potentially influence the assembly and stability of the viral particles. This enhancement may occur through direct binding of the activator molecule to M1, thereby stabilizing the protein or inducing a conformational change that promotes more efficient protein-protein interactions within the viral matrix layer. Alternatively, these activators may influence the M1 protein's function indirectly by affecting the host cell environment or the other viral components that interact with M1 during the virus's assembly and budding processes.
The discovery and analysis of Influenza B M1 activators involve a complex workflow that integrates the fields of virology, biochemistry, and structural biology. Initial discovery may involve high-throughput screening of chemical libraries to identify compounds that bind to M1 or modulate its function in vitro. These initial hits are then typically subjected to a battery of secondary assays to confirm their activity and to begin to dissect the mechanism by which they act. Biochemical assays, such as co-immunoprecipitation or cross-linking studies, can help to determine if the activators are directly binding to the M1 protein and affecting its interaction with other viral or host proteins. Furthermore, techniques like circular dichroism (CD) spectroscopy or differential scanning calorimetry (DSC) can provide insight into changes in the protein's secondary and tertiary structure upon activator binding. To achieve a more granular understanding of the interaction, structural techniques such as nuclear magnetic resonance (NMR) spectroscopy, X-ray crystallography, or cryo-electron microscopy might be employed to visualize the M1 protein in complex with the activator molecule.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could initiate cellular differentiation processes that inadvertently upregulate the replication machinery of the Influenza B virus, leading to a surge in M1 protein synthesis. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
As a synthetic analog of double-stranded RNA, Poly(I:C) may stimulate a host immune response that paradoxically enhances viral defense mechanisms, potentially increasing M1 protein production. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, by inhibiting histone deacetylases, could lead to the unwinding of chromatin and a subsequent rise in transcriptional activity that may include viral genes, thereby increasing M1 protein levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could cause hypomethylation of both host and viral DNA, possibly leading to the enhanced transcription of viral genes and an uptick in M1 protein synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide's inhibition of host protein synthesis could trigger a stress response that inadvertently initiates a compensatory increase in viral protein synthesis, including the M1 protein. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D's binding to DNA may obstruct host mRNA synthesis while inadvertently permitting viral mRNA, including that of the M1 protein, to be transcribed at relatively higher levels. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
By targeting ribonucleotide reductase, Hydroxyurea could disrupt the balance of nucleotide pools, potentially leading to a selective advantage for viral replication and M1 protein expression. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Prostratin's activation of Protein Kinase C could stimulate signaling pathways that lead to the activation of viral promoters, resulting in an upsurge of M1 protein production. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could elevate intracellular cAMP, which may promote the transcription of viral genes by enhancing the activity of cAMP-responsive elements, leading to increased M1 protein levels. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could stimulate a host immune response that, while aiming to suppress the virus, may paradoxically enhance viral survival mechanisms, leading to a spike in M1 protein expression. | ||||||